Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives $15.35 Consensus Price Target from Analysts

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $15.35.

A number of research analysts have recently commented on SBRA shares. Mizuho increased their price objective on Sabra Health Care REIT from $15.00 to $17.00 and gave the company a "buy" rating in a report on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft initiated coverage on Sabra Health Care REIT in a research note on Tuesday, January 30th. They set a "buy" rating and a $21.00 price target on the stock. Finally, Wedbush restated an "outperform" rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, February 29th.

Get Our Latest Research Report on SBRA

Sabra Health Care REIT Stock Down 1.0 %

Shares of SBRA traded down $0.14 during mid-day trading on Monday, reaching $14.34. The company's stock had a trading volume of 1,703,343 shares, compared to its average volume of 2,064,913. Sabra Health Care REIT has a 12-month low of $10.30 and a 12-month high of $14.91. The stock has a market cap of $3.32 billion, a PE ratio of 286.80, a price-to-earnings-growth ratio of 5.22 and a beta of 1.16. The company has a debt-to-equity ratio of 0.86, a current ratio of 3.41 and a quick ratio of 3.41. The company's 50 day moving average is $13.98 and its 200 day moving average is $14.05.


Sabra Health Care REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Shareholders of record on Tuesday, February 13th were paid a $0.30 dividend. The ex-dividend date was Monday, February 12th. This represents a $1.20 annualized dividend and a dividend yield of 8.37%. Sabra Health Care REIT's dividend payout ratio (DPR) is currently 2,400.00%.

Institutional Trading of Sabra Health Care REIT

Several hedge funds have recently modified their holdings of SBRA. CWM LLC lifted its holdings in shares of Sabra Health Care REIT by 363.5% in the 3rd quarter. CWM LLC now owns 1,780 shares of the real estate investment trust's stock valued at $25,000 after buying an additional 1,396 shares during the period. Tennessee Valley Asset Management Partners acquired a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at approximately $25,000. Chilton Capital Management LLC acquired a new stake in shares of Sabra Health Care REIT in the 1st quarter valued at approximately $26,000. RVW Wealth LLC acquired a new stake in shares of Sabra Health Care REIT in the 3rd quarter valued at approximately $30,000. Finally, Point72 Hong Kong Ltd acquired a new stake in shares of Sabra Health Care REIT in the 2nd quarter valued at approximately $31,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Company Profile

(Get Free Report

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Featured Stories

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

Search Headlines: